Countries North America

Providence Therapeutic Holdings and Ontario Institute for Cancer Research Announce Landmark Collaboration for mRNA Drug Discovery and Development

Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines ...

 May 24, 2024 | News

CAS Unveils CAS BioFinder Discovery Platform™ to Transform Drug Discovery Process

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced the launch of the CAS BioFinder Discovery Platf...

 May 22, 2024 | News

Allucent Secures $25.5 Million Award for Decentralized COVID-19 Trial

 Allucent, a global mid-sized clinical research organization (CRO), announced  that it received a project award valued at $25.5 million...

 May 16, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

 May 08, 2024 | News

Takara Bio USA Introduces Innovative Lenti-X Transduction Sponge for Gene Delivery

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market disso...

 May 07, 2024 | News

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

 May 03, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

 May 03, 2024 | News

GE HealthCare Gains FDA 510(k) Clearance for Advanced Portrait VSM Vital Signs Monitor

GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor...

 April 30, 2024 | News

Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...

 April 30, 2024 | News

Asimov Launches New Cell Line Service, Expanding LV Edge System to Boost Therapeutic Production

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the la...

 April 29, 2024 | News

MiLaboratories and Miltenyi Biotec Forge Partnership to Advance Next-Generation Therapies

MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership...

 April 29, 2024 | News

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

"This submission was the culmination of several years of development activities and the establishment of a Good Manufacturing Practices (GMP) manufacturing...

 April 19, 2024 | News

Artiva Biotherapeutics Initiates First U.S. Trial of Allogeneic NK Cell Therapy for Lupus Nephritis

Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-bas...

 April 18, 2024 | News

Singapore-Based Respiree Expands to U.S., Establishes Presence at Johnson & Johnson Innovation Hub in South San Francisco

Respiree announced that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francis...

 April 16, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close